Skip to main content
Drug bottle and Pill

Compare Tremfya vs. Dupixent

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Tremfya (guselkumab) and Dupixent (dupilumab) are both injectable medications used to treat different inflammatory conditions, but they have some key differences. Tremfya is specifically approved for moderate-to-severe plaque psoriasis and active psoriatic arthritis, while Dupixent is used for a wider range of conditions, including eczema, asthma, sinus congestion with nasal polyps, eosinophilic esophagitis, and prurigo nodularis. Tremfya works by blocking the IL-23 protein to reduce inflammation, whereas Dupixent blocks multiple proteins responsible for inflammation. Tremfya is typically injected every 8 weeks after the initial doses, while Dupixent's dosing varies from weekly to monthly depending on the condition being treated. Tremfya is only available as a brand-name medication, making it potentially more expensive, whereas Dupixent also lacks a generic form. Both medications can cause injection site reactions and increase the risk of infections, but Dupixent is more likely to cause eye inflammation and has a broader range of side effects.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.